Vertex Pharmaceuticals Incorporated
VRTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $12.0B | $11.0B | +8.9% |
| Operating income | $4.17B | −$233M | |
| Net income | $3.95B | −$536M |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $3.44B | $3.08B | +11.8% |
| Operating income | $713M | $1.19B | −39.9% |
| Net income | $654M | $1.08B | −39.6% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Vertex's revenue in FY2025?
- $12.0B in FY2025 (Fiscal year ended Dec 31, 2025), +8.9% vs $11.0B a year earlier, per its 10-K filed Feb 2026.
- Was Vertex profitable in FY2025?
- Yes: net income was $3.95B and operating income $4.17B in FY2025.
- What was Vertex's revenue in Q3 2026?
- $3.44B (+11.8% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.